Skip to Main Content

Advertisement

Skip Nav Destination

First Edition

Research Article April 23 2024
Clonal Hematopoiesis of Indeterminate Potential in Patients with Immunoglobulin Light Chain AL Amyloidosis
Research Article April 19 2024
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Research Article April 19 2024
Amphiregulin, ST2,and REG3α Biomarker Risk Algorithms as Predictors of Non-Relapse Mortality in Patients with Acute GVHD
Research Article April 19 2024
Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies
Research Article April 19 2024
Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease
Research Article April 19 2024
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: Pooled analysis of 5 clinical trials
Research Article April 19 2024
HLA reduction of human T cells facilitates generation of immunologically multi-compatible cellular products
Research Article April 19 2024
Biased agonism of protease-activated receptor-1 regulates thrombo-inflammation in murine sickle cell disease
Research Article April 19 2024
Co-targeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma
Research Article April 19 2024
Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome
Research Article April 19 2024
Lysosomal Degradation Targets Mutant Calreticulin and the Thrombopoietin Receptor in Myeloproliferative Neoplasms
Research Article April 19 2024
Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data
Research Article April 19 2024
O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies
Research Article April 19 2024
A 69 long non-coding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML
Research Article April 16 2024
Decision theoretical foundation of clinical practice guidelines: an extension of the ASH thrombophilia guidelines
Research Article April 16 2024
Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol
Letter April 16 2024
Infections in lymphoma patients treated with bispecific antibodies: A systematic review and meta-analysis.
Research Article April 15 2024
Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for VTE prophylaxis
Research Article April 15 2024
Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia
Research Article April 12 2024
Clonal Hematopoiesis and Inflammation in the VasculaturE (CHIVE): a prospective, longitudinal cohort and biorepository
Review Article April 12 2024
2022 Review of the 2019 American Society of Hematology Guidelines on Immune Thrombocytopenia
Letter April 12 2024
Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms
Research Article April 12 2024
Unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies
Research Article April 11 2024
Dual role of signaling pathways in myeloma requires cell-type specific targeting of ligand-receptor interactions.
Research Article April 11 2024
Organ Involvement in Adults with BPDCN is Associated with Sun Exposure History, TET2 and RAS Mutations, and Survival
Research Article April 10 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
Research Article April 10 2024
Myeloablative Vs. Non-Myeloablative Consolidation for Primary Central Nervous System Lymphoma: Results of Alliance 51101
Research Article April 10 2024
Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy
Research Article April 10 2024
An indirect comparison of acalabrutinib with and without obinutuzumab versus zanubrutinib in treatment-naive CLL
Research Article April 10 2024
Haploidentical transplantation in primary refractory/relapsed secondary versus de novo AML: from the ALWP/EBMT
Research Article April 9 2024
Final Outcomes from a Phase 2 Trial of Posoleucel in Allogeneic Hematopoietic Cell Transplant Recipients
Research Article April 9 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM
Research Article April 9 2024
Long-Term Treatment With Selective PI3Kδ Inhibitor Leniolisib in Adults With Activated PI3Kδ Syndrome
Research Article April 9 2024
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET Cohort
Research Article April 9 2024
Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in T- and/or NK-cell lymphoma patients
Research Article April 9 2024
Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood
Research Article April 9 2024
Hemolysis events in the Phase 3 PEGASUS study of pegcetacoplan in patients with paroxysmal nocturnal hemoglobinuria
Review Article April 9 2024
Distinguishing ASH Clinical Practice Guidelines from Other Forms of ASH Clinical Advice
Research Article April 9 2024
Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder of women
Reply April 9 2024
In Reply: Fine and Gray or Cox model?
Research Article April 8 2024
Hemojuvelin mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3
Research Article April 8 2024
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia
Research Article April 4 2024
CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy
Letter April 3 2024
Industry Payments to American Society of Hematology Clinical Practice Guideline Authors
Letter April 2 2024
Thrombocytosis and megakaryocyte changes associated with PRCA
Research Article April 2 2024
Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A
Review Article April 2 2024
Immune status and selection of patients for immunotherapy in myeloma: a Proposal
Research Article April 2 2024
CD70-specific CAR-NK cells expressing IL-15 for the treatment of CD19-negative B cell malignancy
Research Article April 2 2024
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance
Research Article March 29 2024
Integrated analyses reveal unexpected complex inversion and recombination in RH genes
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement